Desktop Site
|
14 Aug 24 | 15:59
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
BSE SENSEX
79,105.88
+149.85
+0.19 %
Corporate Announcement
Security Code
544210
Company
Emcure Pharmaceuticals Ltd
Exchange Received Time
13/08/2024 21:06:25
Exchange Disseminated Time
13/08/2024 21:06:39
Time Taken
00:00:14
Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2024 |
8/13/2024 9:06:39 PM
The Board of Directors of the Company at its meeting held today i.e. Tuesday, August 13, 2024 has inter-alia approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2024, as reviewed and recommended by the Audit Committee. Pursuant to Regulation 33 of the Listing Regulations, we are enclosing herewith the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2024, along with the Limited Review Reports on the aforesaid Results as issued by B S R & Co. LLP, Chartered Accountants, Auditors of the Company, enclosed as Annexure A. Press Release outlining key updates on the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2024, is also enclosed herewith as Annexure B.
Attachment
<< Back
Recently Viewed